Physician

Curtis J Daniels, MD

According to 2025 Medicare claims, Curtis Daniels, MD (NPI: 1407833320) practices adult congenital heart disease in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-1240. Daniels is affiliated with the CVS ACO (ACO ID: A5407), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Daniels' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 171 traditional Medicare patients, billed 445 HCPCS/CPT codes, and received $34,256 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 882 prescription claims across 70 beneficiaries totaling $6,419,586 in drug costs, led by Opsumit (Macitentan). DME data shows 203 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $31,032 and ending at $34,256. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,948,172 to $6,419,586. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $41,929 and ending at $34,534.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	180	388	$31,032
2016	216	454	$33,939
2017	194	344	$21,178
2018	233	604	$46,403
2019	222	501	$37,221
2020	175	378	$26,343
2021	189	390	$27,234
2022	166	383	$28,132
2023	155	314	$22,195
2024	171	445	$34,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	117	1,184	$2,948,172
2016	118	1,286	$2,902,548
2017	117	1,222	$3,410,520
2018	104	1,066	$3,933,385
2019	97	1,049	$3,903,625
2020	83	1,035	$4,562,849
2021	69	668	$3,416,962
2022	64	670	$4,593,213
2023	77	794	$6,563,392
2024	70	882	$6,419,586

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	314	$742,799
2016	N/R	342	$982,298
2017	N/R	308	$1,243,616
2018	N/R	589	$1,771,205
2019	N/R	379	$1,762,186
2020	N/R	347	$2,010,961
2021	N/R	284	$1,665,337
2022	N/R	222	$938,069
2023	N/R	162	$882,134
2024	N/R	203	$658,643

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	43	48	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	45	167	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	47	61	$63
99238	Hospital discharge day management, 30 minutes or less	36	36	$58
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	26	31	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	200	5,895	$2,477,147
Uptravi	Selexipag	71	2,122	$1,693,278
Orenitram Er	Treprostinil Diolamine	36	1,080	$818,788
Tyvaso Dpi	Treprostinil	23	644	$523,571
Ambrisentan	Ambrisentan	61	2,070	$260,474

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J3285	Injection, treprostinil, 1 mg	N	N/R	36	$625,119
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	23	$16,118
K0455	Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)	Y	N/R	35	$9,737
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	47	$4,588
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	30	$2,308

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Curtis J. Daniels, MD?

Tedicare shows public-source Medicare data for Curtis J. Daniels, MD (NPI 1407833320), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Curtis J. Daniels, MD have ACO affiliation data?

Curtis J. Daniels, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Curtis J. Daniels, MD?

Curtis J. Daniels, MD is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Curtis J. Daniels, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.